STOCK TITAN
  1. Home
  2. News
  3. OGI

Organigram Holdings Inc. Common Shares - OGI STOCK NEWS

Welcome to our dedicated page for Organigram Holdings Common Shares news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings Common Shares stock.

OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.

OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.

OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.

Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.

OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.

News

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

Rhea-AI Summary
Organigram Holdings Inc. (NASDAQ: OGI) has been recognized on the 2024 Report on Business 'Women Lead Here' list for gender diversity, with 50% of its executive leadership team being women. The company stands out in the cannabis industry for its significant female leadership presence. Organigram prioritizes inclusivity, flexibility, and equality in the corporate landscape, with over 46% of its workforce being women.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
none
-
News

Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales

Rhea-AI Summary
Organigram Holdings Inc. celebrates SHRED brand's success, surpassing $200 million in yearly retail sales with innovative products that revolutionized the cannabis industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.25%
Tags
none
-
News

Organigram Successfully Closes Previously Announced Underwritten Public Offering

Rhea-AI Summary
Organigram Holdings Inc. successfully closes a public offering, raising C$28.8 million in gross proceeds to enhance its balance sheet. The Company sold 8,901,000 Units at C$3.23 per Unit, including the exercise of the over-allotment option. Each Unit comprises a Common Share and a Warrant. The net proceeds will be used for growth initiatives and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
offering
News

Organigram Announces Pricing of Overnight Marketed Public Offering

Rhea-AI Summary
Organigram Holdings Inc. announces a public offering of units, led by ATB Securities Inc., to sell 7,740,000 Units at C$3.23 per Unit, aiming to raise approximately C$25 million. The Company grants underwriters an over-allotment option to purchase up to an additional 1,161,000 Units. Each Unit includes a Common Share and a Warrant, with the Warrant exercisable at C$3.65 per share for four years post-closing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.37%
Tags
offering
-
News

Organigram Announces Launch of Overnight Marketed Public Offering

Rhea-AI Summary
Organigram Holdings Inc. announces a public offering of units for gross proceeds of approximately C$25 million. The offering will be completed through underwriting agreements with ATB Securities Inc. and is expected to close on April 2, 2024. The company plans to use the net proceeds for growth initiatives, acquisitions, and investments in the cannabis and hemp markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.37%
Tags
offering
-
News

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment

Rhea-AI Summary
Organigram Holdings Inc. (OGI) announces a $2 million minority investment in Open Book Extracts, a leading hemp-derived extracts and products provider. The investment aims to expand Organigram's footprint in the U.S. market and explore potential product launches, research collaborations, and international opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.35%
Tags
none
News

Organigram Receives Health Canada’s Final Redetermination on Jolts

Rhea-AI Summary
Organigram Holdings Inc. announced that Health Canada has reclassified its Edison Jolts lozenge products as edible cannabis despite evidence supporting ingestible classification. The decision follows a court ruling on procedural fairness. Organigram is disappointed and is evaluating next steps.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.35%
Tags
none
-
News

Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty

Rhea-AI Summary
Organigram Holdings Inc. supports the Standing Committee on Finance's recommendation to adjust the excise duty framework for the cannabis industry. Licensed producers currently pay up to 35% of revenue in excise duties, hindering competitiveness and innovation. The proposed 10% ad valorem rate reduction could significantly benefit the sector's sustainability and support government objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.09%
Tags
none
-
News

Organigram Reports First Quarter Fiscal 2024 Results

Rhea-AI Summary
Organigram Holdings Inc. achieved positive cash flow and solidified its market position in Canada, announcing a $124.6 million strategic investment from BAT. They improved margins, maintained market positions, and introduced new products. Despite a decline in net revenue, the company showed positive Adjusted EBITDA and cash flow. Key financial metrics and balance sheet data highlight the company's financial standing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.55%
Tags
earnings
News

Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024

Rhea-AI Summary
Organigram Holdings Inc. (OGI) will report earnings for its first quarter fiscal 2024 on February 13, 2024. The conference call to discuss the results will be held at 8:00 am Eastern Time on the same day. The registration link for the call and webcast details are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
conferences earnings

FAQ

What is the current stock price of Organigram Holdings Common Shares (OGI)?

The current stock price of Organigram Holdings Common Shares (OGI) is $1.52 as of November 22, 2024.

What is the market cap of Organigram Holdings Common Shares (OGI)?

The market cap of Organigram Holdings Common Shares (OGI) is approximately 166.1M.

What is OrganiGram Holdings Inc.?

OrganiGram Holdings Inc. is a Canadian company engaged in the production of indoor-grown cannabis for medical patients and adult recreational users.

What types of cannabis products does OrganiGram offer?

OrganiGram offers a range of cannabis products under brands such as Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, Trailblazer, Tremblant Cannabis, and Laurentian.

Where is OrganiGram Holdings Inc. based?

OrganiGram Holdings Inc. is based in Atlantic Canada.

How can I contact OrganiGram's client services team?

You can contact OrganiGram's client services team by calling 1-855-961-9420.

Is OrganiGram involved in research and development?

Yes, OrganiGram places a strong emphasis on research and development to enhance its cultivation techniques and product offerings.

What regulations does OrganiGram operate under?

OrganiGram operates under Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Is OrganiGram Holdings Inc. publicly traded?

Yes, OrganiGram Holdings Inc. is publicly traded under the symbol OGI.

Where can I find more information about OrganiGram?

You can find more information about OrganiGram by visiting their website at www.organigram.ca.

What makes OrganiGram's cannabis products unique?

OrganiGram's cannabis products are unique due to their high quality, organically grown nature, and diverse brand portfolio.

Has OrganiGram recently expanded its product lineup?

Yes, OrganiGram has recently added Tremblant Cannabis and the artisanal craft brand, Laurentian to its product lineup.

Stock OGI logo
Organigram Holdings Inc. Common Shares

Nasdaq:OGI

OGI Rankings

#4015 Ranked by Market Cap
N/A Ranked by Dividends

OGI Stock Data

166.12M
75.87M
31.32%
9.73%
2.11%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto